Please try another search
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out in Sweden and internationally. It offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced AI to analyze the patient's coronary blood flow. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Fredrik Buch | 69 | 2021 | Independent Director |
Philip Siberg | 50 | 2021 | Independent Chairman of the Board |
David Erlinge | - | - | Member of Clinical Advisory Board |
John Cleland | - | - | Member of Clinical Advisory Board |
Morten Bottcher | - | - | Member of Clinical Advisory Board |
Marlou Janssen-Counotte | 58 | 2020 | Independent Director |
Ulf Rosén | 63 | 2014 | Independent Director |
Peter Clemmensen | - | - | Member of Clinical Advisory Board |
Deepak R. Talreja | - | 2023 | Medical Advisor |
Dave Braun | - | 2024 | Member of the Advisory Board |
Kenneth Nelson | 48 | 2024 | Member of the Advisory Board |
Saumil R. Oza | - | 2024 | Member of the Advisory Board |
Mikael Thorén | 60 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review